Bavarian Nordic has $340 million orders for its mpox, smallpox vaccine in 2025

Danish biotech Bavarian Nordic said on Friday the order book for delivery of its vaccine for mpox and smallpox in 2025 currently totals around 2.40 billion crowns ($340 million), including previously announced deferred revenue.